Abiopharma

LITHIUM AMERICAS CORP. (LAC) Reports the reporting period Financial Results LITHIUM AMERICAS CORP. (LAC) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: Not disclosed
• Net Income: (0.02
• EPS: Not disclosed
• Cash and equivalents: $530
  • anticipated in such 9 information. As such, readers are cautioned not to place undue reliance on this information, and that this information may not be appropriate for any other purpose, including investment purposes. The Company’s actual results could differ materially from those anticipated in any FLS as a result of the risk factors described under Part I, Item 1A, “Risk Factors” in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2025
  • expected in Q3 2026
  • targeting mechanical completion in late 2027